CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis

Cutaneous leishmaniasis (CL) affects the lives of 0.7–1 million people every year causing lesions that take months to heal. These lesions can result in disfiguring scars with psychological, social and economic consequences. Antimonials are the first line of therapy for CL, however the treatment is l...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PLoS Negl Trop Dis
Hlavní autoři: Thacker, Seth G, McWilliams, Ian L., Bonnet, Beatrice, Halie, Lydia, Beaucage, Serge, Rachuri, Swaksha, Dey, Ranadhir, Duncan, Robert, Modabber, Farrokh, Robinson, Stephen, Bilbe, Graeme, Arana, Byron, Verthelyi, Daniela
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7075640/
https://ncbi.nlm.nih.gov/pubmed/32109251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0008050
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky